Access cutting-edge metastatic or locally advanced solid tumors with microsatellite instability-high (msi-h) or mismatched repair deficiency (dmmr) treatment through this clinical trial at a research site in Westbrook. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Westbrook location
Preparing your pre-screening questions…
Access metastatic or locally advanced solid tumors with microsatellite instability-high (msi-h) or mismatched repair deficiency (dmmr) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related metastatic or locally advanced solid tumors with microsatellite instability-high (msi-h) or mismatched repair deficiency (dmmr) treatment provided free
Check if you qualify for this metastatic or locally advanced solid tumors with microsatellite instability-high (msi-h) or mismatched repair deficiency (dmmr) clinical trial in Westbrook, ME
No-Cost Study Care
Local to Westbrook
Convenient for ME residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The primary objectives of this trial are to evaluate the safety profile of AMG 436 and to determine the maximum tolerated dose (MTD) and/or the recommended dose for AMG 436 as monotherapy and in combination with other anti-cancer therapies in participants with MSI-H/dMMR solid tumors.
Sponsor: Amgen
Yes, this clinical trial (NCT07403721) has an active research site in Westbrook, ME that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for metastatic or locally advanced solid tumors with microsatellite instability-high (msi-h) or mismatched repair deficiency (dmmr) treatment options in Westbrook, ME, this clinical trial (NCT07403721) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Westbrook research site is actively enrolling participants for this clinical trial. You'll receive care from experienced metastatic or locally advanced solid tumors with microsatellite instability-high (msi-h) or mismatched repair deficiency (dmmr) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all metastatic or locally advanced solid tumors with microsatellite instability-high (msi-h) or mismatched repair deficiency (dmmr) clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Westbrook — not just this study.
Browse Leukemia Trials in Westbrook →